PROBENECID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Probenecid, and what generic alternatives are available?
Probenecid is a drug marketed by Aurobindo Pharma Usa, Ivax Sub Teva Pharms, Lederle, Rising, Watson Labs, Watson Labs Teva, Ani Pharms, Beecham, Impax Labs, Novast Labs, and Sandoz. and is included in fourteen NDAs.
The generic ingredient in PROBENECID is colchicine; probenecid. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROBENECID?
- What are the global sales for PROBENECID?
- What is Average Wholesale Price for PROBENECID?
Summary for PROBENECID
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 14 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 70 |
| Patent Applications: | 4,156 |
| Drug Prices: | Drug price information for PROBENECID |
| DailyMed Link: | PROBENECID at DailyMed |
Recent Clinical Trials for PROBENECID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| TrippBio, Inc. | Phase 1 |
| Guangdong Raynovent Biotech Co., Ltd | Phase 1 |
| United States Department of Defense | Phase 3 |
Medical Subject Heading (MeSH) Categories for PROBENECID
Anatomical Therapeutic Chemical (ATC) Classes for PROBENECID
US Patents and Regulatory Information for PROBENECID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | PROBENECID | probenecid | TABLET;ORAL | 084211-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | PROBENECID AND COLCHICINE | colchicine; probenecid | TABLET;ORAL | 083734-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rising | PROBENECID | probenecid | TABLET;ORAL | 217020-001 | Nov 20, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
